- We will send in 10–14 business days.
/images/books/15009835/9783639662092.jpg)
- Author: Dalia Medhat
- Publisher: Scholars' Press
- ISBN-10: 3639662091
- ISBN-13: 9783639662092
- Format: 15.2 x 22.9 x 0.4 cm, minkšti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
Cancer and the immune system share a complex relationship, where immune cells play dual roles in tumor progression and suppression. The immune system can detect and eliminate nascent tumor cells through immune surveillance, primarily driven by T cells, natural killer cells, and antigen-presenting cells. However, cancer often evades immune control through mechanisms such as immune checkpoint inhibition, regulatory T cell activation, and secretion of immunosuppressive factors.The advent of immunotherapy has revolutionized cancer treatment, employing strategies like immune checkpoint inhibitors, adoptive T cell therapy, and cancer vaccines. Despite significant successes, challenges remain, including immune resistance, treatment toxicity, and limited efficacy in certain cancers.Future directions emphasize personalized medicine, combination therapies, and the development of novel biomarkers to predict treatment response. Understanding tumor-immune interactions at molecular and cellular levels is key to overcoming existing challenges and harnessing immunity for more effective cancer therapies.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 22d.09:33:48
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Dalia Medhat
- Publisher: Scholars' Press
- ISBN-10: 3639662091
- ISBN-13: 9783639662092
- Format: 15.2 x 22.9 x 0.4 cm, minkšti viršeliai
- Language: English English
Cancer and the immune system share a complex relationship, where immune cells play dual roles in tumor progression and suppression. The immune system can detect and eliminate nascent tumor cells through immune surveillance, primarily driven by T cells, natural killer cells, and antigen-presenting cells. However, cancer often evades immune control through mechanisms such as immune checkpoint inhibition, regulatory T cell activation, and secretion of immunosuppressive factors.The advent of immunotherapy has revolutionized cancer treatment, employing strategies like immune checkpoint inhibitors, adoptive T cell therapy, and cancer vaccines. Despite significant successes, challenges remain, including immune resistance, treatment toxicity, and limited efficacy in certain cancers.Future directions emphasize personalized medicine, combination therapies, and the development of novel biomarkers to predict treatment response. Understanding tumor-immune interactions at molecular and cellular levels is key to overcoming existing challenges and harnessing immunity for more effective cancer therapies.
Reviews